Trial of Trastuzumab Deruxtecan in Previously Treated HER2
Trial of Trastuzumab Deruxtecan in Previously Treated HER2
Recruiting · NCT06750484 · Registry updated 2026-09-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trial of Trastuzumab Deruxtecan in Previously Treated HER2 | Breast Cancer Metastatic | Recruiting | Phase 2 | 2026-09-03 | NCT06750484 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| Breast Cancer Research Foundation | 40 |
| Daiichi Sankyo | 144 |
| Yale University | 458 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Emory Winship Cancer Institute | Atlanta | United States | 29 |
| University of Rochester Medical Center | Rochester | United States | 162 |
| Yale University | New Haven | United States | 44 |